Oct 1 |
Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
|
Oct 1 |
Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
|
Oct 1 |
Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
|
Sep 30 |
Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
|
Sep 30 |
$1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
|
Sep 30 |
Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
|
Sep 28 |
Here are the Medicare Part D drugs expected to face 2025 price negotiations
|
Sep 27 |
Amazon to provide opioid overdose drug in workplace
|
Sep 25 |
FTC weighs in on reverse-payment generic delay case involving Gilead, Teva
|
Sep 23 |
Teva touts safety profile of once monthly schizophrenia therapy
|